Birth plans, and what actually goes wrong: the realistic-expectations piece

A birth plan is a useful document for thinking through what you want. It is a poor predictor of what your birth will look like. Most labors deviate from the plan in at least one significant way, and the deviations are not failures — they are how labor actually behaves once a real body and a real baby get involved. The point of this piece is not to talk you out of having preferences. It is to give you the realistic-expectations briefing that most childbirth classes don't have time for, so the deviations don't feel like betrayal when they happen.

This is the medical-and-practical companion to our earlier piece on birth trauma and postpartum PTSD (Yildiz et al. 2017). The mental-health side of a hard birth lives there. The "what is actually happening in the room and why" lives here.

Why ACOG quietly stopped saying "birth plan"

The American College of Obstetricians and Gynecologists has shifted, over the last decade, away from the language of "birth plan" toward "birth preferences." This is not a stylistic change. It is the reflection of two practical observations from the labor-and-delivery literature.

The first observation is that fixed plans correlate with worse subjective birth experience when the plan can't be followed (Lothian 2006; multiple subsequent reviews). A patient who arrives with a tightly specified checklist and meets a clinical situation that requires deviation tends to leave the experience more distressed than a patient who arrived with explicit, branched preferences. The plan itself becomes the thing the parent has to grieve, on top of whatever the medical event was.

The second observation is that informed flexibility — knowing in advance which interventions you might face and having pre-thought-through preferences for the common ones — produces better-feeling births than either a rigid plan or no plan at all. ACOG Committee Opinion 766 (2019), "Approaches to Limit Intervention During Labor and Birth," is essentially built around this principle: support physiologic labor where possible, intervene where indicated, and treat the patient as the decision-maker on the trade-offs in between.

The ARRIVE trial and why it changed practice

In 2018, the New England Journal of Medicine published the ARRIVE trial (Grobman et al. 2018, NEJM 379:513–523). It randomized about 6,100 low-risk first-time pregnant patients to either elective induction at 39 weeks or expectant management. The headline finding: the elective-induction group had a lower cesarean rate (about 19% vs 22%), with no increase in adverse perinatal outcomes.

ARRIVE shifted American obstetric practice meaningfully. Many practices that previously offered induction at 39 weeks only for medical indications now offer elective 39-week induction as a routine option. ACOG's response (2018 practice advisory) was measured: a reasonable option to discuss in shared decision-making for low-risk nulliparas, not a recommended default.

The trial is contested for reasonable reasons. Subsequent meta-analyses (Sotiriadis et al. 2019, BJOG; others) generally support the cesarean-reduction finding but note real-world generalizability concerns: ARRIVE was conducted at high-volume academic centers with specific induction protocols that may not transfer to community hospitals, and patient-experience outcomes (pain, satisfaction, longer time on the labor floor) tend to favor spontaneous labor when it occurs.

The honest summary: if you are a low-risk first-time pregnancy at 39 weeks, induction is a reasonable option that probably modestly reduces your cesarean odds; spontaneous labor is also a reasonable option that has its own modest advantages on patient experience.

Cesarean rates, by indication

The US cesarean rate has been roughly flat in the low 30s for the last decade (CDC NCHS Births: Final Data, ~32% in 2023). Among first-time, low-risk, term, singleton, vertex (NTSV) pregnancies — the cleanest comparison group — the rate is closer to 25–26%, with wide variation between hospitals.

The most common reasons primary cesareans actually happen, roughly in order:

• Failure to progress / arrest of dilation — the largest single category, accounting for roughly a third of primary cesareans in most US registries.
• Non-reassuring fetal heart rate (Category II or III tracings) — the second largest category. Continuous electronic fetal monitoring is sensitive but not specific.
• Suspected intra-amniotic infection (chorioamnionitis).
• Malpresentation — breech, transverse, or other non-vertex position. External cephalic version (ECV) is offered around 37 weeks for some breech presentations, with success rates roughly 50–60%.
• Prior cesarean and TOLAC limitations.
• Maternal medical indications — severe preeclampsia, placenta previa, placental abruption, uterine rupture, cord prolapse.

The variation between hospitals is enormous — primary cesarean rates can vary by a factor of two or three between hospitals serving demographically similar populations. The hospital you deliver at matters more than most patients realize.

What "arrest of dilation" actually means

The 2014 ACOG–SMFM Consensus on Safe Prevention of the Primary Cesarean Delivery (Caughey, Cahill, Spong et al.) tightened the criteria for diagnosing labor arrest, specifically because the older criteria — based on Friedman's 1950s–1960s curves — were diagnosing arrest too aggressively and contributing to the rising primary cesarean rate.

Under the current criteria:

• Latent labor — the long, slow, sometimes-multi-day phase before about 6 cm — is no longer treated as having a "normal" length. Slow latent labor by itself is not arrest.
• Active labor begins at roughly 6 cm dilation, not 4 cm as in the older curves.
• Active-phase arrest is diagnosed only with at least 6 cm dilation, ruptured membranes, and either no cervical change for 4 hours of adequate contractions or no change for 6 hours of inadequate contractions despite augmentation.
• Second-stage arrest is diagnosed at 3 hours for nulliparas (4 hours with epidural) and 2 hours for multiparas (3 hours with epidural).

These thresholds matter because they are why you may be at the same dilation, in the same hospital bed, for many more hours than your friend was at her birth ten years ago. The longer thresholds are an explicit, evidence-based effort to reduce primary cesareans for arrest.

Chorioamnionitis: the infection that often triggers escalation

Intra-amniotic infection — historically called chorioamnionitis, often shortened to "chorio" on the labor floor — occurs in roughly 1–4% of term deliveries (Tita & Andrews 2010, Clinics in Perinatology). Risk factors are well characterized:

• Prolonged rupture of membranes (especially over 18 hours)
• Prolonged labor
• Multiple cervical exams after rupture
• Internal fetal monitoring
• Group B Strep colonization without adequate intrapartum prophylaxis
• Bacterial vaginosis or other genital tract infections

The clinical picture is usually a maternal fever (≥38.0 °C / 100.4 °F) with one or more supporting findings. ACOG Committee Opinion 712 (2017) renamed the condition "intrauterine inflammation or infection or both" (Triple I) to capture the reality that fever in labor is sometimes inflammation rather than true infection.

The management is broad-spectrum IV antibiotics and acceleration toward delivery. Chorio is one of the most common reasons a labor that was going fine suddenly pivots to "we need to deliver this baby in the next few hours" — which often means cesarean if vaginal delivery is not imminent.

Postpartum hemorrhage: the complication you want your team ready for

Postpartum hemorrhage (PPH) — typically defined as cumulative blood loss of 1,000 mL or more, or any blood loss with signs of hypovolemia — occurs in roughly 4–6% of US deliveries. It is the leading cause of maternal mortality globally and consistently a top-three cause in the United States (ACOG Practice Bulletin 183, 2017, reaffirmed 2022).

The four classic causes — the "Four Ts":

• Tone — uterine atony, the failure of the uterus to contract down after delivery. Atony causes about 70–80% of PPH.
• Trauma — lacerations of the cervix, vagina, perineum, or uterine rupture.
• Tissue — retained placenta or retained products of conception.
• Thrombin — coagulation disorders, including DIC.

The standard escalation for atonic PPH:

• Bimanual uterine massage and bladder emptying.
• Uterotonic medications — oxytocin, methylergonovine (Methergine), carboprost (Hemabate), misoprostol.
• Tranexamic acid (TXA) — the WOMAN trial (2017, Lancet) supports its use within 3 hours of delivery.
• Intrauterine balloon tamponade — Bakri balloon or similar.
• Uterine artery embolization — interventional radiology.
• Surgical management — including B-Lynch and other compression sutures, vessel ligation, and, as a last resort, peripartum hysterectomy.

The B-Lynch suture (B-Lynch et al. 1997, BJOG 104:372–375) is one of the genuinely useful surgical innovations of the last thirty years. When applied early — before the patient has lost so much blood that DIC has developed — it reduces the rate of progression to hysterectomy substantially.

Massive transfusion protocols

When PPH crosses into massive hemorrhage — generally defined as ≥1,500 mL of blood loss, or transfusion needs anticipated to exceed 4 units of red cells — most US labor floors now have a defined massive transfusion protocol (MTP) that releases pre-typed blood products in fixed ratios.

The current evidence-based ratio comes from the PROPPR trial (Holcomb et al. 2015, JAMA 313:471–482), which compared 1:1:1 versus 1:1:2 ratios of plasma, platelets, and red cells. The 1:1:1 group had improved early hemostasis and fewer deaths from exsanguination at 24 hours. Most obstetric MTPs are built around the same 1:1:1 ratio.

For a patient on the receiving end of an MTP activation, the practical experience is that the room fills with people quickly, blood products arrive in coolers, and decisions are being made on a scale of minutes. Knowing in advance that this is what an MTP looks like — that the chaos is the protocol working, not failing — is one of the things that retrospectively helps people make sense of a scary postpartum event.

ICU admission after delivery

Roughly 1–3 per 1,000 US deliveries result in maternal admission to an ICU. The most common reasons:

• Postpartum hemorrhage requiring large-volume transfusion or surgical management
• Hypertensive emergencies — severe preeclampsia with end-organ involvement, HELLP syndrome, eclampsia
• Pulmonary embolism — pregnancy and the postpartum period are the highest-risk windows for VTE in otherwise healthy adults
• Sepsis — most often arising from chorioamnionitis, endometritis, or pyelonephritis
• Cardiac complications — peripartum cardiomyopathy, arrhythmias
• Anesthesia-related complications

ICU admission is not the same as a near-miss. Many ICU stays after delivery are short, observational, and primarily about having continuous monitoring and the right staffing during a 24–48-hour window. But it is a real category, and the patients who experience it are the patients most likely to develop the postpartum PTSD picture we covered in the birth-trauma piece.

Postpartum thyroiditis: the recovery curve nobody warns you about

Roughly 5–10% of postpartum people develop postpartum thyroiditis in the first year after delivery (Stagnaro-Green 2012; ATA guidelines). The classic pattern is triphasic: a transient hyperthyroid phase (1–4 months postpartum), followed by a euthyroid period, then a hypothyroid phase (4–8 months postpartum), then resolution — or, in 20–40% of affected patients, persistent permanent hypothyroidism.

Risk factors include positive thyroid peroxidase (TPO) antibodies, a personal or family history of autoimmune thyroid disease, type 1 diabetes, and prior episodes (which recur in subsequent pregnancies in roughly 70% of cases).

The reason this matters is that the symptoms — fatigue, weight changes, mood changes, hair loss, palpitations — overlap exactly with the symptoms of normal postpartum recovery and the underslept reality of having a newborn. It is consistently underdiagnosed. If your fatigue or mood is not improving on the timeline you expected, asking your provider for a TSH (with reflex to free T4 and TPO antibodies) is reasonable.

The recovery curve people don't expect

ACOG Committee Opinion 736 (2018), "Optimizing Postpartum Care," reframed the postpartum period as the "fourth trimester" specifically because the standard six-week-checkup model was missing too much of what happens in those weeks.

• Postpartum diuresis: most people are visibly more swollen on day 2–3 postpartum than at delivery, then lose several pounds of fluid over days 3–7.
• Anemia-related fatigue: most postpartum people are mildly to moderately anemic, even with normal blood loss. The energy curve in weeks 2–6 is heavily shaped by hemoglobin recovery.
• Pelvic floor recovery: pelvic floor symptoms are essentially universal in the first weeks after a vaginal delivery and present in cesarean recoveries too. Pelvic floor PT is appropriate at any point past the 6-week checkup if symptoms persist.
• Cesarean recovery: incision pain peaks at days 2–4, walking comfortably usually returns by week 2, full healing of the scar takes months.
• Mental health timeline: baby blues in weeks 1–2 are normative. Postpartum depression, anxiety, OCD, and PTSD typically emerge in weeks 2–24, sometimes later.
• Sleep architecture: most postpartum people will not have a single uninterrupted 6-hour sleep stretch for 3–6 months. The cumulative effect on cognition, mood, and physical recovery is large.

What a useful birth plan actually looks like

Given all of the above, a useful birth plan is not a checklist of refusals. It is a short, honest document with branching preferences, a designated decision-maker, and explicit informed-consent language for the most common interventions. A workable structure:

• A one-paragraph summary of your overall preferences — physiologic vs medicated, who you want present, what kind of support (doula, partner, family) you want.
• Branched preferences for the common interventions, in "if X, then I prefer Y" form. Example: "If continuous monitoring becomes necessary, I prefer telemetry rather than wired monitoring if available." "If a cesarean becomes necessary, I prefer a clear drape, immediate skin-to-skin, and delayed cord clamping where clinically reasonable."
• Explicit informed-consent acknowledgments for the common interventions: epidural, oxytocin augmentation, episiotomy, vacuum or forceps, and cesarean.
• A designated decision-maker for emergencies. If you become unable to make decisions, who do you want speaking for you?
• A note on what matters most to you about the experience, for the team to know if things deviate from the plan.

The deepest version of this — and the version most labor and delivery nurses recommend — is to write the plan, share it with your provider in advance, and then go in prepared to abandon it. The plan's purpose is to make you think through the decisions so the decisions are not new in the moment.

Birth is one of the few medical events where the outcome is, in most cases, very good, and the experience is, in many cases, not what was imagined. Holding both of those at once is the realistic-expectations posture. The baby being healthy is not the only thing that matters. It is also not a small thing.

Sources

• ACOG Committee Opinion 766: Approaches to Limit Intervention During Labor and Birth. Obstet Gynecol. 2019;133(2):e164–e173.
• ACOG Committee Opinion 736: Optimizing Postpartum Care. Obstet Gynecol. 2018;131(5):e140–e150.
• ACOG Committee Opinion 712: Intrapartum Management of Intraamniotic Infection. 2017.
• ACOG Practice Bulletin 183: Postpartum Hemorrhage. 2017 (reaffirmed 2022).
• Caughey AB, Cahill AG, Guise J-M, Rouse DJ. Safe Prevention of the Primary Cesarean Delivery (ACOG–SMFM Obstetric Care Consensus). Am J Obstet Gynecol. 2014;210(3):179–193.
• Grobman WA, Rice MM, Reddy UM, et al. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women (ARRIVE). NEJM. 2018;379:513–523.
• Sotiriadis A, Petousis S, Thilaganathan B, et al. Maternal and perinatal outcomes after elective induction at 39 weeks: a meta-analysis. BJOG. 2019.
• CDC NCHS. Births: Final Data for 2023.
• Tita ATN, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010;37(2):339–354.
• B-Lynch C, Coker A, Lawal AH, et al. The B-Lynch surgical technique for the control of massive postpartum haemorrhage. BJOG. 1997;104(3):372–375.
• Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio (PROPPR). JAMA. 2015;313(5):471–482.
• WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage. Lancet. 2017;389(10084):2105–2116.
• Stagnaro-Green A. Approach to the Patient with Postpartum Thyroiditis. J Clin Endocrinol Metab. 2012.
• Yildiz PD, Ayers S, Phillips L. The prevalence of posttraumatic stress disorder in pregnancy and after birth: a systematic review and meta-analysis. J Affect Disord. 2017;208:634–645.
• Lothian JA. Birth plans: the good, the bad, and the future. JOGNN. 2006;35(2):295–303.